Refeeding Like Syndrome in Acute Disease
RLS
Dose-response Relation Between the Development of a Refeeding-like Syndrome and Sodium Balance in Patients Undergoing Acute Abdominal Surgery
1 other identifier
observational
48
1 country
1
Brief Summary
The refeeding syndrome has been reported without any evidence of prolopnged semistarvation, thus being different from the traditional disease. The investigators wanted to investigate, if sodium infusions could be part of the explanation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedFirst Submitted
Initial submission to the registry
July 8, 2021
CompletedFirst Posted
Study publicly available on registry
July 19, 2021
CompletedJuly 26, 2021
July 1, 2021
3.2 years
July 8, 2021
July 19, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
sodium balance
correlation between sodium balance and occurrence of the refeeding syndrome
7 days
Secondary Outcomes (3)
plasma phosphate
7 days
urinary excretion of phosphate
7 days
phosphate balance
7 days
Interventions
Acute surgery for acute abdominal disease
Eligibility Criteria
Consecutive, adult patients for acute, abdominal surgery were asked top be included and observed until discharge or up to seven days postoperatively with daily sodium and phosphate balance measurements.
You may qualify if:
- age \> 18 yr
- ready for acute surgery
- able to understand and cooperate.
You may not qualify if:
- pregnancy or breastfeeding
- renal insufficiency (p-creatinine\>400 micr mol/l)
- re-operations
- expected hospital stay \< 24 hours.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jens Rikardt Andersenlead
- University of Copenhagencollaborator
Study Sites (1)
Herlev University Hospital
Herlev, 2730, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
jens R Andersen
University of Copenhagen
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor, Primary Investigator
Study Record Dates
First Submitted
July 8, 2021
First Posted
July 19, 2021
Study Start
April 1, 2018
Primary Completion
June 1, 2021
Study Completion
June 1, 2021
Last Updated
July 26, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share